Top Page
Access Co., Ltd.
(4813)
Access Co., Ltd. (4813) vs. iShares MSCI Japan ETF (EWJ)
Access Co., Ltd. Business Overview & Revenue Model
Access Co., Ltd. Financial Statement Overview
| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.62B | 19.22B | 15.93B | 15.12B | 13.06B | 9.85B |
| Gross Profit | 5.82B | 8.12B | 7.06B | 6.58B | 3.52B | 977.79M |
| EBITDA | -5.39B | -1.25B | -3.69B | 3.23B | 1.44B | 1.23B |
| Net Income | -7.61B | -3.40B | -5.38B | -280.18M | -2.68B | -3.05B |
Balance Sheet | ||||||
| Total Assets | 14.61B | 17.10B | 23.18B | 21.56B | 21.31B | 29.12B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 5.41B | 10.81B | 10.92B | 11.88B | 15.24B |
| Total Debt | 902.25M | 977.15M | 1.03B | 212.03M | 332.34M | 0.00 |
| Total Liabilities | 7.20B | 10.31B | 13.13B | 6.43B | 4.41B | 3.73B |
| Stockholders Equity | 7.42B | 6.79B | 10.05B | 15.12B | 16.89B | 25.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.40B | -420.94M | -1.18B | -1.84B | -2.07B |
| Operating Cash Flow | 0.00 | -3.94B | 1.13B | 2.24B | 953.69M | 641.94M |
| Investing Cash Flow | 0.00 | -1.58B | -1.07B | -3.72B | -2.92B | -2.35B |
| Financing Cash Flow | 0.00 | -19.04M | -50.88M | -27.14M | -1.32B | -36.95M |
Access Co., Ltd. Technical Analysis
Access Co., Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥23.81B | 16.06 | ― | 0.73% | 17.86% | 21.52% | |
74 Outperform | ¥26.98B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
74 Outperform | ¥29.21B | 35.99 | ― | ― | 29.61% | 93.16% | |
72 Outperform | ¥29.89B | 13.94 | ― | 3.40% | 12.64% | 30.73% | |
68 Neutral | ¥28.25B | -28.94 | ― | 2.51% | 8.88% | 2.72% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
44 Neutral | ¥22.87B | -6.86 | ― | ― | 25.89% | -285.21% |
Access Co., Ltd. Corporate Events
ACCESS CO., LTD. said it will book foreign exchange gains, non-operating expenses, and extraordinary losses in the fourth quarter of the fiscal year ending January 2026, including a ¥212 million FX gain that turned a prior loss into a ¥39 million annual gain and a ¥70 million impairment charge at Network unit IP Infusion, bringing total year impairment to ¥275 million. The company also recorded significant non-consolidated write-downs and provisions on loans and equity interests in its U.S., European and Taiwanese subsidiaries that do not affect consolidated figures, while consolidated sales rose 20.6% to ¥19.2 billion on strong IoT and Network demand, losses widened at the operating level due to higher Network R&D spending, and a major Evollabs contract will contribute revenue mainly from the fiscal year ending January 2027 onward.
Non-consolidated results were hit by ¥3.87 billion in bad debt losses and provisions for doubtful accounts on loans to overseas subsidiaries, plus valuation losses totaling nearly ¥1.0 billion on shares and investments in those units, underscoring financial pressure in certain international operations but with no direct consolidated P&L impact. Despite a deeper operating and ordinary loss, the net loss attributable to owners narrowed to ¥3.4 billion, helped by the absence of prior-year special investigation costs and confirmation that the company has fully collected the USD 30 million due in 2025 under the Evollabs network business contract, providing liquidity support ahead of future revenue recognition from that deal.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen561.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS Co., Ltd., a Tokyo-listed software and platform provider for networked and embedded systems, reported consolidated results for the fiscal year ended Jan. 31, 2026 that showed solid top-line expansion but persistent losses. The company’s balance sheet weakened over the year, with lower total assets and equity, while cash and cash equivalents declined sharply, indicating tighter financial flexibility.
Net sales rose 20.6% year on year to ¥19.2 billion, but the group remained in the red, posting an operating loss of ¥2.7 billion and a net loss attributable to owners of the parent of ¥3.4 billion, albeit narrower than the prior year’s loss. Equity and the equity ratio fell as net assets declined to ¥6.8 billion, operating cash flow turned negative by nearly ¥3.9 billion, and management maintained a zero-dividend policy, underscoring a continued focus on internal funding amid a forecast for further revenue growth and a return to operating profit in the next fiscal year.
For the fiscal year ending Jan. 31, 2027, the company projects net sales of ¥23.0 billion, with a swing to operating profit of ¥800 million and net profit of ¥610 million, signaling an anticipated earnings recovery. Interim results for the six months to July 31, 2026 are also expected to show higher sales but a continued net loss, suggesting that the turnaround is back-end loaded and that stakeholders will face another period of near-term pressure before any meaningful improvement in profitability materializes.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen561.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. has withdrawn its consolidated financial forecast for the fiscal year ending January 2026 after its board determined that revenue recognition for a large and complex three-year, USD 70 million licensing and services contract signed by U.S. subsidiary IP Infusion with UAE-based Evollabs Tech FZ-LLC may differ materially from earlier assumptions. The company now expects less revenue than previously forecast to be recognized in the current fiscal year and more to be shifted into subsequent years, and warns that the resulting hit to sales and operating profit for the year could be significant; it has therefore set all forecast figures to “to be determined” until it can recalculate guidance, while also disclosing that part of the 2025 cash due under the contract remains unpaid, which it attributes to procedural delays but continues to monitor for any issues requiring further disclosure.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen557.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. has submitted an internal control improvement plan and status report to the Tokyo Stock Exchange after being designated a “Security on Special Alert” in August 2025 due to deficiencies in its internal control systems. Developed by the current management together with a Recurrence Prevention Committee and external experts, and based on findings from a June 2025 special investigation report, the plan revises earlier remediation measures, adds new governance and control enhancements, and establishes ongoing monitoring of implementation progress as the company seeks to have the special alert designation lifted and restore confidence among shareholders, investors, and business partners.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen557.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. announced that its U.S. subsidiary IP Infusion Inc. is facing a payment delay under a three-year, USD 70 million license and service contract for its OcNOS network operating system with UAE-based Evollabs Tech FZ-LLC. Of the USD 30 million scheduled to be paid by the end of 2025, USD 20 million remains unpaid as of January 5, 2026, and the company is currently confirming the payment status with Evollabs while continuing collection efforts, noting that it will provide further updates if any additional disclosure-worthy events occur.
The most recent analyst rating on (JP:4813) stock is a Hold with a Yen563.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. announced that it will again postpone the timely disclosure of its internal control improvement plans and status report, shifting the planned release from late December 2025 to January 2026. The delay follows the Tokyo Stock Exchange’s earlier designation of the company as a Security on Special Alert and the imposition of a listing agreement penalty, which triggered a series of remedial steps including an investigation by a Special Investigation Committee, formulation of recurrence-prevention policies, and submission of draft plans to Japan Exchange Regulation. While much of the remediation process has been implemented or partially implemented, the company says it needs more time to finalize the improvement plans, and it has apologized to shareholders, investors and business partners for the added uncertainty, indicating that the eventual disclosure will be key to assessing the progress of its governance and internal control reforms.
The most recent analyst rating on (JP:4813) stock is a Hold with a Yen563.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.
ACCESS CO., LTD. announced that its U.S. subsidiary IP Infusion has signed a three-year license and service agreement worth USD 70 million with UAE-based Evollabs Tech for the provision of its OcNOS network operating system, associated maintenance and support, and development of additional functions. The deal positions OcNOS as a key software platform for white-box hardware that Evollabs plans to sell mainly in the Middle East, reflecting rising demand for scalable, cost-efficient data center and GPU networking solutions. IP Infusion has so far received USD 10 million of the USD 30 million it expects to collect by the end of 2025, and while some payments are overdue, the project is described as progressing smoothly, with the company pledging timely updates on collections and noting that the transaction, already factored into its January 2026 earnings forecast, could still affect consolidated results depending on final accounting treatment.
The most recent analyst rating on (JP:4813) stock is a Sell with a Yen483.00 price target. To see the full list of analyst forecasts on Access Co., Ltd. stock, see the JP:4813 Stock Forecast page.